Skip to main content
. 2023 Nov 20;64(3 Suppl 1):E1–E89. doi: 10.15167/2421-4248/jpmh2023.64.3s1

Tab. XXIV.

Summary of base case results.

Hydrophilic Uncoated Incremental
Cost per patient (discounted) € 75.677 € 66.670 € 9.007
QALYs per patient (discounted) 8.62 7.99 0.63
Life years per patient (undiscounted) 20.65 19.56 1.10
Incremental cost effectiveness ratio (ICER) € 14.275
Net monetary benefit (NMB) per patient € 3.612
Net health benefit (NHB) per patient 0.18